Physician profile
Bree Fleck
NPI 1356854657
$1,291.58
in general payments reported to CMS, 2019-2025
20 companies · $671 in 2025
The $671 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $13.34 · 2024: $476 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.58 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $329.78 | 2022-2025 | Interstim |
| Ferring Pharmaceuticals INC. | $107.22 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $99.99 | 2024-2025 | |
| Endo USA, INC. | $98.22 | 2024-2025 | Aveed, Xiaflex |
| Janssen Biotech, INC. | $97.40 | 2025 | Erleada |
| Teleflex LLC | $88.57 | 2024 | Urolift |
| Pfizer INC. | $70.30 | 2025 | |
| Olympus America INC. | $51.63 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $50.92 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $39.86 | 2022-2023 | Myrbetriq |
| Procept Biorobotics Corporation | $36.40 | 2025 | |
| Sumitomo Pharma America, INC. | $35.91 | 2025 | Orgovyx |
| Urovant Sciences INC | $30.29 | 2022 | |
| Endo Pharmaceuticals INC. | $30.03 | 2022-2024 | Xiaflex, Aveed |
| Coloplast Corp | $28.39 | 2024-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $27.92 | 2022 | |
| Accord Healthcare, INC. | $19.01 | 2025 | |
| Telix Pharmaceuticals | $18.59 | 2025 | Illuccix |
| Immunitybio, INC. | $15.75 | 2025 | |
| Abbvie INC. | $15.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bree Fleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.